According to Pfizer's financial results, the company reported that its revenue rose in the last quarter of 2020 to approximately $11.7 billion, compared to about $10.4 billion during the same quarter of 2019, marking a 12% increase.
The company expects to achieve sales of $15 billion from its vaccine developed in collaboration with the German company BioNTech against the coronavirus by the end of 2021. Sales of its coronavirus vaccine reached approximately $154 million in the last quarter of the year.
